I'm sure many (including myself) had the same thoughts went the stock hit $5 on the otrexup approval....18 months later the stock has lost 60% of the value. Moral of the story: it's hard to put a lot of faith in the pipeline when management has not proven they can execute.
I didn't hear the cc but I thumbed through the transcript...really odd thing to day by management. Companies get sued all the especially as they get bigger. It doesn't really instill a sense of confidence to me when mangagment says they were distracted by a single suit.
How do I know? I don't but you guys are using the word "revenue" in your posts, not net income, which led me to believe that you guys were basing the eps on revenue
Also hard to win when management said they were comfortable with cash positon at last cc then they dilute. Honestly, I haven't heard one convincing explanation about this move. Perhaps one does exist, I just haven't heard it.
Hey bud, no need to take your frustrations out on me for your poor timing in adding 38k shares before a secondary! Funny how you stopped posting script numbers after that terrible move.
stay losing my friend!
I bet you were saying $5/share was a gift price and people should be buying hand over fist when oxtrexup was approved too...
Just like $13 is 2013, 14 in 2014, etc? At $11, the company would be horribly overvalued.
Typical...bearish without any facts to support to support thesis and won't put his money where his mouth is. Maybe if you are right with the short you will be able to move out of your mom's basement
Without even clicking the post I knew you would take the recent developments as nothing but sunshine and rainbows for ATRS.